AUD257.75
0.01% yesterday
Australia, Dec 30, 06:10 am CET
ISIN
AU000000PME8
Symbol
PME

Pro Medicus Target price 2024 - Analyst rating & recommendation

Pro Medicus Classifications & Recommendation:

Buy
36%
Hold
55%
Sell
9%

Pro Medicus Price Target

Target Price AUD226.35
Price AUD257.75
Deviation
Number of Estimates 10
10 Analysts have issued a price target Pro Medicus 2025 . The average Pro Medicus target price is AUD226.35. This is lower than the current stock price. The highest price target is
AUD300.00 16.39%
register free of charge
, the lowest is
AUD140.00 45.68%
register free of charge
.
A rating was issued by 11 analysts: 4 Analysts recommend Pro Medicus to buy, 6 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Pro Medicus stock has an average upside potential 2025 of . Most analysts recommend the Pro Medicus stock at Hold.

Sales and Margin forecast 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Jun '24 2025
Estimates
Revenue Million AUD 161.50 215.24
29.30% 33.28%
EBITDA Margin 74.77% 76.86%
1.73% 2.79%
Net Margin 51.08% 52.56%
5.34% 2.90%

10 Analysts have issued a sales forecast Pro Medicus 2025 . The average Pro Medicus sales estimate is

AUD215m
Unlock
. This is
33.28% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
AUD226m 39.88%
Unlock
, the lowest is
AUD203m 25.70%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 AUD162m 29.30%
2025
AUD215m 33.28%
Unlock
2026
AUD284m 31.82%
Unlock
2027
AUD356m 25.57%
Unlock
2028
AUD419m 17.66%
Unlock

10 Analysts have issued an Pro Medicus EBITDA forecast 2025. The average Pro Medicus EBITDA estimate is

AUD165m
Unlock
. This is
37.00% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
AUD178m 47.48%
Unlock
, the lowest is
AUD155m 28.35%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 AUD121m 31.55%
2025
AUD165m 37.00%
Unlock
2026
AUD224m 35.29%
Unlock
2027
AUD285m 27.29%
Unlock

EBITDA Margin

2024 74.77% 1.73%
2025
76.86% 2.79%
Unlock
2026
78.88% 2.63%
Unlock
2027
79.97% 1.38%
Unlock

4 Pro Medicus Analysts have issued a net profit forecast 2025. The average Pro Medicus net profit estimate is

AUD113m
Unlock
. This is
37.15% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
AUD124m 50.38%
Unlock
, the lowest is
AUD102m 23.67%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 AUD82.5m 36.21%
2025
AUD113m 37.15%
Unlock
2026
AUD167m 47.85%
Unlock
2027
AUD216m 28.98%
Unlock

Net Margin

2024 51.08% 5.34%
2025
52.56% 2.90%
Unlock
2026
58.96% 12.18%
Unlock
2027
60.56% 2.71%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Jun '24 2025
Estimates
Earnings Per Share AUD 0.79 1.08
36.21% 36.71%
P/E 237.86
EV/Sales 124.41

4 Analysts have issued a Pro Medicus forecast for earnings per share. The average Pro Medicus <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

AUD1.08
Unlock
. This is
36.71% higher
Unlock
than earnings per share in the financial year 2024. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
AUD1.19 50.63%
Unlock
, the lowest is
AUD0.98 24.05%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 AUD0.79 36.21%
2025
AUD1.08 36.71%
Unlock
2026
AUD1.60 48.15%
Unlock
2027
AUD2.07 29.38%
Unlock

P/E ratio

Current 325.08 99.47%
2025
237.86 26.83%
Unlock
2026
160.87 32.37%
Unlock
2027
124.73 22.47%
Unlock

Based on analysts' sales estimates for 2025, the Pro Medicus stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

124.41
Unlock
and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of
125.12
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 165.81 111.92%
2025
124.41 24.97%
Unlock
2026
94.38 24.14%
Unlock
2027
75.16 20.36%
Unlock
2028
63.88 15.01%
Unlock

P/S ratio

Current 166.76 110.56%
2025
125.12 24.97%
Unlock
2026
94.92 24.14%
Unlock
2027
75.59 20.36%
Unlock
2028
64.24 15.01%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today